HIV 1 News and Research

RSS

Anti-AIDS gel shows promise

Dr. Ian McGowan, a professor of medicine at the University of Pittsburgh who is leading a second-phase study of the gel said, “These are early results, but [they] help set the stage for current and future trials of rectal microbicides and the development of a rectal-specific formulation of tenofovir gel.” Researchers have focused on the use of microbicides such as tenofovir, as a preventive treatment to be used in vaginal sex. However, scientists think unprotected anal sex is much more risky.

1 Mar 2011

Scientists to launch international working group to tackle HIV

More than 30 scientists gathered for a one-day meeting prior to the 18th Conference on Retroviruses and Opportunistic Infections to launch an international working group on HIV reservoirs and strategies to control them.

1 Mar 2011

Positive preliminary data from SB-728-902 Phase 1 trial against HIV/AIDS presented at 18th CROI

Sangamo BioSciences, Inc. announced today the presentation of positive preliminary clinical data from its Phase 1 trial.

1 Mar 2011

Social networking websites can increase risky sexual behaviors in homeless youth: New study

A new UCLA AIDS Institute study suggests that the use of social networking websites by homeless youth can lead to an increase in risky sexual behaviors. But interestingly, homeless kids who used these sites were also more likely to have been tested for sexually transmitted infections and to be better informed about preventing such infections and HIV.

1 Mar 2011

Tenofovir gel may help reduce risk of HIV from anal sex

A gel developed to protect against HIV during vaginal sex produced a strong antiviral effect when used in the rectum, according to an early-phase study presented today at the 18th Conference on Retroviruses and Opportunistic Infections (CROI). The results, based on rectal tissue biopsies sampled from HIV-negative men and women who used the product daily for one week, provide the first-ever evidence that tenofovir gel could help reduce the risk of HIV from anal sex, even though the vaginal gel formulation may not be optimal for rectal use.

28 Feb 2011

19th annual EJAF Academy Awards Viewing Party raises nearly $4 million to fight against HIV/AIDS

The 19th annual Elton John AIDS Foundation Academy Awards Viewing Party hosted by Sir Elton John and David Furnish raised nearly $4 million for the fight against HIV/AIDS. The gala, which took place on Sunday, February 27, at the Pacific Design Center in Los Angeles, was co-sponsored by Chopard and Jo & Raffy Manoukian.

28 Feb 2011

Immunitor to present latest results from imm01 trial in tuberculosis patients at African conference

Immune Network Ltd. advises that Immunitor will present latest results from its imm01 clinical trial in tuberculosis patients in Abuja, Nigeria at the 18th Union TB and Lung Diseases Conference of the African Region, 2nd to 5th March, 2011.

28 Feb 2011

MEPs, OETC visit new TB vaccine trial site to express support for candidate development

Emergent BioSolutions Inc. announced that a joint delegation of Members of the European Parliament and representatives from the Oxford-Emergent Tuberculosis Consortium today visited the trial site where MVA85A, the world's most clinically advanced tuberculosis vaccine candidate in development, is being studied in a Phase IIb infant efficacy clinical trial.

28 Feb 2011

New research may shed light on how HIV virus reactivates from latency

New research enhances the current knowledge of how human immunodeficiency virus type-1, which causes AIDS, controls the cell cycle of cells that it infects. The new findings may shed light on how the virus reactivates after entering a dormant state, called latency.

28 Feb 2011

House, Senate leaders continue negotiations on FY11 budget; global health advocates protest spending cuts

Federal budget negotiations continued on Thursday, "as Senate Democrats looked for targets for cuts in the remaining months of fiscal 2011 and House Republicans appeared ready to unveil a stopgap plan that would make deep reductions over the next two weeks," CQ reports.

28 Feb 2011

STD testing for elderly may be covered by Medicare

According to a new report testing for sexually transmitted diseases (STDs) may soon be covered by Medicare plans for the elderly. The Centers for Medicare and Medicaid Services has announced that they are considering adding these tests as part of standard Medicare health insurance plans. At present the national health insurance program already pays for HIV tests. Centers for Medicare and Medicaid Services (CMS) officials are expected to announce a draft decision by August 24.

28 Feb 2011

Targets against MRSA in microgravity

NASA astronauts onboard Space Shuttle Discovery's final mission to the International Space Station (ISS) will carry out the eleventh scientific payload for Astrogenetix, a commercial biotech company based out of Austin, Texas. The research on STS-133 will focus on changes that occur to methicillin-resistant Staphylococcus aureus (MRSA) in microgravity, which can be targeted to create new vaccines and therapeutics.

25 Feb 2011

Researchers explain genetic differences that distinguish early-transmitting HIVs-viruses

A new finding from scientists at the National Institutes of Health could help efforts to design vaccines and other prevention tools to block HIV in the early stages of sexual transmission, before infection takes hold. Researchers at the NIH National Institute of Allergy and Infectious Diseases have helped explain genetic differences that can distinguish some early-transmitting HIVs-viruses found in an infected individual within the first month after infection-from forms of HIV isolated later in infection.

25 Feb 2011

Advocates say ending violence against women must be top priority for U.N. women

Nearly three quarters of women's rights advocates say ending violence against women must be a top priority for U.N. Women, according to a report released Wednesday at the Commission on the Status of Women in New York, Inter Press Service reports.

25 Feb 2011

Roundup: In Ariz., Senate panel takes steps to end Medicaid; Mass. Gov. starts sales pitch for payment reform

A Republican proposal to retain solvency in a key state health care fund is making headway at the Capitol, despite the tumultuous ride reform has taken this session. The fund — which supports MinnesotaCare, a state-sponsored program for about 140,000 "working poor" residents — is set to run a $150 million deficit by 2013.

25 Feb 2011

Planned parenthood cuts draw opposition from state, local officials

New York City Mayor Michael Bloomberg and two Democratic governors spoke out against House Republicans' family planning cuts Tuesday as the Senate prepares to take up the stop-gap funding bill for the rest of the year.

24 Feb 2011

Senate Majority Leader will attempt to pass new one-month stopgap measure to avoid government shutdown

Senate Majority Leader Harry Reid said on Tuesday "he will attempt to pass a 'clean' one-month stopgap funding measure at current spending levels when the Senate returns next week, in a bid to avoid a government shutdown," CQ reports.

24 Feb 2011

Viewpoints: GOP's 'war' on family planning; state workers' health costs; health law already hurting U.S.

A bill passed by the Republican-controlled House last week would cut $75 million in funding to Planned Parenthood that is spent for family planning assistance.

24 Feb 2011

New vaccine offers hope against Hepatitis C

Immunology: Three percent of the world's population is currently infected by hepatitis C. The virus hides in the liver and can cause cirrhosis and liver cancer, and it's the most frequent cause of liver transplants in Denmark.

24 Feb 2011

Researchers identify low-dose, two-drug cocktail that reduces noise-induced hearing loss in mice

Whether on a battlefield, in a factory or at a rock concert, noise-induced hearing loss is one of the most common hazards people face. Researchers at Washington University School of Medicine in St. Louis have identified a low-dose, two-drug cocktail that reduces hearing loss in mice when given before they are exposed to loud noise. The drugs, already FDA-approved for other conditions, also treat hearing loss after noise exposure.

23 Feb 2011

HIV 1 News and Research

Anti-AIDS gel shows promise

Scientists to launch international working group to tackle HIV

Positive preliminary data from SB-728-902 Phase 1 trial against HIV/AIDS presented at 18th CROI

Social networking websites can increase risky sexual behaviors in homeless youth: New study

Tenofovir gel may help reduce risk of HIV from anal sex

19th annual EJAF Academy Awards Viewing Party raises nearly $4 million to fight against HIV/AIDS

Immunitor to present latest results from imm01 trial in tuberculosis patients at African conference

MEPs, OETC visit new TB vaccine trial site to express support for candidate development

New research may shed light on how HIV virus reactivates from latency

House, Senate leaders continue negotiations on FY11 budget; global health advocates protest spending cuts

STD testing for elderly may be covered by Medicare

Targets against MRSA in microgravity

Researchers explain genetic differences that distinguish early-transmitting HIVs-viruses

Advocates say ending violence against women must be top priority for U.N. women

Roundup: In Ariz., Senate panel takes steps to end Medicaid; Mass. Gov. starts sales pitch for payment reform

Planned parenthood cuts draw opposition from state, local officials

Senate Majority Leader will attempt to pass new one-month stopgap measure to avoid government shutdown

Viewpoints: GOP's 'war' on family planning; state workers' health costs; health law already hurting U.S.

New vaccine offers hope against Hepatitis C

Researchers identify low-dose, two-drug cocktail that reduces noise-induced hearing loss in mice

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News